Hair Health

Hair aging usually presents as two overlapping processes: loss of density and progressive graying. Both are influenced by genetics, hormones, nutrition, inflammation, oxidative stress and local follicular biology. They should be treated as distinct problems because interventions that slow androgen-driven miniaturization do not necessarily restore pigment, and strategies aimed at pigmentation generally do not reverse follicle miniaturization.

Androgenetic hair loss

The most common pattern of hair loss in men and women is androgenetic alopecia. In genetically susceptible follicles, dihydrotestosterone (DHT) shortens the growth phase and progressively miniaturizes the follicle. The strongest established treatments are minoxidil and antiandrogen approaches such as finasteride in appropriate patients. Benefits depend on continued treatment and vary by sex, age, pattern and baseline severity.

Minoxidil prolongs anagen and influences follicular blood flow and cellular signaling. Finasteride reduces conversion of testosterone to DHT by inhibiting 5-alpha-reductase. These treatments have substantially stronger evidence than most botanical alternatives, although side-effect profiles and contraindications differ.

Botanicals and topical adjuncts

Saw palmetto, pumpkin-seed oil, caffeine, rosemary oil and topical melatonin have all been investigated. Small trials suggest possible effects on hair count or shedding, but the evidence base is far thinner and less standardized than for minoxidil or finasteride. Variability in extracts, concentrations and study design makes direct comparison difficult.

Rosemary oil is frequently marketed as a natural alternative to minoxidil. A small comparative trial reported improvement in hair count over months, but this should not be interpreted as proof of equivalent efficacy across formulations. Similar caution applies to caffeine shampoos and antioxidant scalp products.

Nutrition and correctable deficiencies

Iron deficiency, low vitamin D, zinc deficiency, inadequate protein intake and, less commonly, clinically meaningful biotin deficiency can contribute to diffuse shedding. Correcting a documented deficiency can substantially improve hair loss caused by that deficiency; taking extra nutrients when levels are already adequate has much less evidence and can sometimes be harmful.

Hair is built largely from keratin, so adequate protein and energy intake matter. Iron supports rapidly dividing matrix cells, zinc participates in numerous enzymes, and copper contributes to pigmentation enzymes. Fatty fish, eggs, legumes, leafy vegetables, nuts, seeds and shellfish can help cover these nutritional requirements as part of an overall balanced diet.

Why hair turns gray

Hair color depends on melanocytes and melanocyte stem cells in the follicle. With age, these cells lose function or are depleted. Genetics is the dominant determinant of timing, but oxidative stress, smoking and some nutritional deficiencies are associated with earlier graying.

Hydrogen peroxide and other reactive oxygen species have been proposed as contributors to pigment loss, partly through impaired melanogenesis and oxidative damage. This has led to interest in catalase, antioxidants and melanogenic precursors. Mechanistic plausibility, however, has not translated into a consistently effective oral treatment for ordinary age-related graying.

Repigmentation claims

PABA, pantothenic acid, L-tyrosine, copper, catalase supplements, Polygonum multiflorum, luteolin and melanocortin-related compounds have all been discussed as potential anti-gray interventions. Evidence ranges from old case reports and animal studies to small uncontrolled human observations. Copper replacement is biologically relevant when deficiency exists, but extra copper does not reliably repigment normal aging hair. Polygonum multiflorum deserves particular caution because clinically important liver injury has been reported.

Occasional spontaneous or treatment-associated repigmentation has been documented with some drugs and after correction of deficiencies, showing that pigment loss is not always absolutely irreversible. These cases are exceptions rather than evidence for a general-purpose anti-gray therapy.

Practical hierarchy of evidence

For patterned hair loss, established pharmacologic therapy, early diagnosis and treatment of nutritional or endocrine causes have the highest expected value. For graying, the evidence is much weaker: avoiding smoking, correcting deficiencies and maintaining general metabolic health are rational, but no supplement has demonstrated reliable restoration of youthful pigmentation in the general population.

Hair biology changes slowly, so meaningful assessment usually requires months rather than days or weeks. Photography under standardized lighting and periodic measurement of density can distinguish true change from normal variation in shedding and styling.